This Government Contract opportunity from Department Of Defense was posted on May 11, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Pharmaceutical Manufacturing and Formulation

Closed

Federal

Submission Closed05/18/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

LEVOFLOXACIN TABLETThe contract pertains to the procurement of Levofloxacin tablets, identified by NSN/Part Number 6505-01-444-6632, with a purchase quantity of one unit under request number 7017178498. The solicitation, designated SPE2DP-26-T-3807, was issued by the Defense Logistics Agency on behalf of the Department of Defense with a posting date of June 15, 2026, and a response deadline set for June 22, 2026. This solicitation is categorized as a federal opportunity without specific set-aside conditions or NAICS code information provided. The contract will be performed within the United States, although exact location details are unspecified. The Defense Logistics Agency is managing the acquisition, and the solicitation details are accessible via a designated DIBBS URL for interested parties.

Defense Logistics Agency

POSTED

DEADLINE

Sole Source Total Parenteral Nutrition (TPN) solutions, including TrophAmine, Plenamine, Nutrilipid, and SMOF Lipid same-day delivery, seven days a weekThis contract involves the sole source procurement of Total Parenteral Nutrition (TPN) solutions, specifically including products such as TrophAmine, Plenamine, Nutrilipid, and SMOF Lipid. The key requirement is for same-day delivery, seven days a week, ensuring continuous availability of these critical nutritional solutions. The solicitation number is HT941026N0069, with the notice posted on June 15, 2026, and a response deadline set for June 30, 2026. The contract falls under the NAICS code 325412, associated with pharmaceutical preparation manufacturing, and is issued by the Defense Health Agency located at Camp Pendleton, California. The place of performance is identified within Washington state, ZIP code 98431, indicating where the deliveries or contract services will be conducted. There is no set-aside designation for this procurement, reflecting an open competitive strategy or a direct sole-source justification. Primary and secondary points of contact are provided for further inquiries, with the primary contact being CHA-ON Gordon. The contract aims to support the Department of Defense’s ongoing medical and nutritional needs for personnel, emphasizing timely and reliable supply chain delivery for essential TPN products.

Defense Health Agency Hcd West

POSTED

DEADLINE

6505--Lab Supplies | Radiopharm | 5-Year Indefinite Delivery/Indefinite Quantity (IDIQ) | VA Pittsburgh Healthcare SystemThe contract solicits bids for the supply of laboratory materials related to radiopharmaceuticals under a five-year indefinite delivery, indefinite quantity (IDIQ) agreement for the VA Pittsburgh Healthcare System. The solicitation, identified by the number 36C24426Q0669, invites vendors to provide these specialized lab supplies consistent with NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. The Department of Veterans Affairs, specifically the 244-NETWORK Contract Office 4 located in Pittsburgh, Pennsylvania, is managing this procurement. Vendors interested in participating must submit their proposals by July 10, 2026, with the solicitation having been posted on June 12, 2026. The contract aims to ensure a steady and flexible supply of radiopharmaceutical lab materials to support healthcare operations over a multi-year period, accommodating variable quantities as needed. The primary point of contact for this contract is Christa L. Stine, a contract specialist reachable via email, facilitating communication and clarifications throughout the solicitation process.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

Supply of PYP Cold VialsThe contract involves the supply of PYP cold vials to the VA Pittsburgh facility, requiring a stringent same-day delivery service within a 2-hour window during business hours. The supplier must ensure the maintenance of the cold chain throughout the delivery process, complying with all relevant regulatory standards to preserve the integrity of the product. This contract is categorized under NAICS code 325412 and is managed by the Department of Veterans Affairs, specifically through the 244-NETWORK Contract Office 4. Responses to this subcontract opportunity must be submitted by July 10, 2026. The contract emphasizes urgency and precision in delivery, reflecting the critical nature of the supplies for the facility's operations. The detailed logistics and regulatory compliance underscore the importance of reliability and quality control in fulfilling the contract requirements. Information about the contract was made available as of June 12, 2026.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

PETNET PharmaceuticalThe Medical Readiness Contracting Office-West plans to award a firm fixed-price sole source contract to PETNET Solutions INC., doing business as Siemens Healthineers, for the supply of FDA-approved radiopharmaceuticals including FDG, NaF, Amyvid, and Posluma. The contract encompasses a base period from October 1, 2026, to September 30, 2027, with an option period extending to September 30, 2028. This contract will be executed under statutory authority FAR 12.102(a), allowing for non-competitive procurement due to the determination that only one source is reasonably available to meet the government's specific needs. The contract falls under the NAICS code 325412 for Pharmaceutical Preparation Manufacturing with a size standard of 1,300 employees. The delivery location for the products will be the William Beaumont Army Medical Center at Fort Bliss, Texas. The notice explicitly states that no competitive proposals will be solicited, and the government will not honor any capability briefings or telephonic inquiries related to this contract. The point of contact for inquiries is Darryl O. Bryant, with a secondary contact being Karina Haddix, both representatives of the Department of Defense’s Medical Readiness Contracting Office-West.

W40M MRC0 West

POSTED

5 days ago

DEADLINE

in 6 days

AI Contract Overview

The contract involves the manufacture of Guaifenesin Extended-Release Tablets, 600 mg, covering all aspects from active pharmaceutical ingredient (API) sourcing and formulation to quality control and batch release testing. The work must adhere to stringent FDA and Defense Logistics Agency (DLA) standards, ensuring compliance with regulatory and military requirements. The production is intended as a subcontract and focuses on pharmaceutical manufacturing under the NAICS code 325412. The place of performance for this contract is located at Fort Stewart, with the Department of Defense’s Medical Supply Chain Pharmaceutical Field Support Activity as the overseeing agency. The contract was posted on May 11, 2026, with responses due by May 18, 2026. This opportunity provides a critical role in supplying quality-controlled and compliant pharmaceutical products to support military medical needs.

General Info

Manufacture of 600mg Guaifenesin tablets meeting FDA and DLA standards for military supply.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

FORT STEWART, GA, 31314-5185, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedMay 11

subcontract

Response DeadlineMay 18

Deadline has passed

Submission Closed

05/18/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressN/A

ContactsNo contact information available

Full Description

Manufacture of Guaifenesin Extended-Release Tablets, 600 mg, including API sourcing, formulation, quality control, and batch release testing in compliance with FDA and DLA standards.